Hemispherx Biopharma Enhances Ampligen Manufacturing and Scientific Capabilities
May 31, 2017 11:38 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, May 31, 2017 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) ("Hemispherx" or the “Company") announced today that it continues to build its manufacturing and scientific...
Hemispherx Biopharma Bolsters Manufacturing and Scientific Capabilities Through Key Consulting and Management Appointments
July 19, 2016 08:35 ET
|
Hemispherx Biopharma, Inc.
Promotes Carol Smith, Ph.D., to Manager of Quality as Part of Manufacturing Optimization Retains Step Change Pharma as Advisor to Strengthen Manufacturing and Technical Infrastructure Retains...